Han G - Search Results

1

Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

Chen X, Lu Y, Shi X, Chen X, Rong D, Han G, Zhang L, Ni C, Zhao J, Gao Y, Wang X. Chen X, et al. Among authors: han g. J Oncol. 2021 Dec 10;2021:3002480. doi: 10.1155/2021/3002480. eCollection 2021. J Oncol. 2021. PMID: 34925507 Free PMC article.

2

Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.

Chen Z, Pu L, Gao W, Zhang L, Han G, Zhu Q, Li X, Wu J, Wang X. Chen Z, et al. Among authors: han g. Oncotarget. 2017 Apr 25;8(17):28959-28970. doi: 10.18632/oncotarget.16330. Oncotarget. 2017. PMID: 28415824 Free PMC article.

3

Impact of insurance status on the survival of gallbladder cancer patients.

Chen Z, Gao W, Pu L, Zhang L, Han G, Zhu Q, Li X, Wu J, Wang X. Chen Z, et al. Among authors: han g. Oncotarget. 2017 Jun 6;8(31):51663-51674. doi: 10.18632/oncotarget.18381. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881677 Free PMC article.

4

A Meta-Analysis of the Diagnostic Accuracy of Circular RNAs in Digestive System Malignancy.

Chen Z, Zhang L, Han G, Zuo X, Zhang Y, Zhu Q, Wu J, Wang X. Chen Z, et al. Among authors: han g. Cell Physiol Biochem. 2018;45(3):962-972. doi: 10.1159/000487291. Epub 2018 Feb 2. Cell Physiol Biochem. 2018. PMID: 29428945 Free article.

5

PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1.

Chen Z, Gao W, Pu L, Zhang L, Han G, Zuo X, Zhang Y, Li X, Shen H, Wu J, Wang X. Chen Z, et al. Among authors: han g. Hepatology. 2018 Sep;68(3):994-1009. doi: 10.1002/hep.29890. Epub 2018 May 21. Hepatology. 2018. PMID: 29572888

6

MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma.

Han G, Zhang L, Ni X, Chen Z, Pan X, Zhu Q, Li S, Wu J, Huang X, Wang X. Han G, et al. Cell Physiol Biochem. 2018;46(6):2261-2270. doi: 10.1159/000489594. Epub 2018 May 3. Cell Physiol Biochem. 2018. PMID: 29734164 Free article.

7

MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.

Chen Z, Zuo X, Zhang Y, Han G, Zhang L, Wu J, Wang X. Chen Z, et al. Among authors: han g. Cell Death Dis. 2018 May 1;9(5):549. doi: 10.1038/s41419-018-0616-8. Cell Death Dis. 2018. PMID: 29748591 Free PMC article.

8

Anti-IL-20 monoclonal antibody suppresses hepatocellular carcinoma progression.

Ding WZ, Han GY, Jin HH, Zhan CF, Ji Y, Huang XL. Ding WZ, et al. Oncol Lett. 2018 Nov;16(5):6156-6162. doi: 10.3892/ol.2018.9402. Epub 2018 Sep 5. Oncol Lett. 2018. PMID: 30333881 Free PMC article.

9

Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma.

Zhang Y, You W, Zhou H, Chen Z, Han G, Zuo X, Zhang L, Wu J, Wang X. Zhang Y, et al. Among authors: han g. Am J Cancer Res. 2018 Oct 1;8(10):2116-2129. eCollection 2018. Am J Cancer Res. 2018. PMID: 30416861 Free PMC article.

10

circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.

Chen Z, Zuo X, Pu L, Zhang Y, Han G, Zhang L, Wu J, Wang X. Chen Z, et al. Among authors: han g. Cancer Sci. 2019 Feb;110(2):568-581. doi: 10.1111/cas.13901. Epub 2019 Jan 4. Cancer Sci. 2019. PMID: 30520539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,785 results

Search Page

Filters